ChromaDex Corporation

Type: Company

Name: ChromaDex Corporation

First reported May 21 2013 - Updated May 21 2013 - 2 reports

Chromadex (CDXC) Insider Builds Stake As Pipeline Develops

Chromadex Corporation (OTC Markets: CDXC) Director Michael Brauser purchased 25,000 shares of common stock on the open market on May 13th, according to a Form 4 filing with the SEC. The purchase, at a price of $0.662 per share, brought the insider?s total ... [Published StockHouse USA - May 21 2013]

Entities: ChromaDex Corporation, Insider, Interclick Inc, Pipeline

First reported May 20 2013 - Updated May 20 2013 - 2 reports

ChromaDex To Present At The Second Annual Marcum LLP MicroCap Conference

SOURCE Marcum LLPIRVINE, Calif. The Company's presentation is scheduled to begin at 2:00 p.m. EDTFor more information and registration, please visit the conference website: http://www.marcumllp.com/microcapAbout ChromaDex®:ChromaDex® is an innovative ... [Published KiiiTV3.com - May 20 2013]

Entities: ChromaDex Corporation, Spherix Incorporated, nicotinamide, curcumin

First reported May 20 2013 - Updated May 20 2013 - 1 reports

ChromaDex, Inc. to Present at the Second Annual MicroCap Conference

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!IRVINE, Calif. , May 20, 2013 /PRNewswire/ -- ChromaDex Corporation (OTCQB: CDXC), an innovative natural products... ... [Published BioSpace - May 20 2013]

Entities: ChromaDex Corporation, OTCQB Marketplace

First reported May 16 2013 - Updated May 16 2013 - 1 reports

SupplySide MarketPlace Review: The “Next Generation” Vitamin B

ChromaDex (Irvine, CA) gave Nutritional Outlook a preview of what it calls the “next generation vitamin B,” which the company plans to roll out this fall. As Frank Jaksch, ChromaDex founder and CEO explained, nicotanimide riboside(NR), as well as other ... [Published Nutritional Outlook - May 16 2013]

Entities: Vitamin B, ChromaDex Corporation, Marketplace, Nicotinamide Adenine Dinucleotide, Prostaglandins

First reported May 15 2013 - Updated May 15 2013 - 2 reports

Natural Products Ingredient Innovator Generating Interest Am. . .

Natural Products Ingredient Innovator Generating Interest Among Investors Institutions and IndustryBaystreet.caCategory: Baystreet NewswireCompany: Emerging Growth Corp.ID: 404199Ticker: OTC:BB:CDXCChromaDex (CDXC) emerging as significant playerDietary ... [Published Equities.com - May 15 2013]

Entities: ChromaDex Corporation, Phillip Frost, Vitamin, Dietary Supplements

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Form 4 ChromaDex Corp. For: May 10 Filed by: Brauser Michael

StreetInsider.com - Form 4 ChromaDex Corp. For: May 10 Filed by: Brauser Michael ... [Published Street Insider - May 14 2013]

Entities: ChromaDex Corporation

First reported May 10 2013 - Updated May 10 2013 - 1 reports

ChromaDex, Inc. Reports Results for the First Quarter 2013

Staying up-to-date has never been simpler. Sign up for the today! IRVINE, Calif., May 10, 2013 /PRNewswire/ -- ChromaDexÂ® Corporation (OTCQB: CDXC) ("ChromaDex" or the "Company"), an innovative natural products company that provides proprietary, science-based ... [Published BioSpace - May 10 2013]

Entities: ChromaDex Corporation, Dietary Supplements, Animal Health

First reported May 10 2013 - Updated May 10 2013 - 2 reports

ChromaDex revenue up 31%

ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, announced today ... [Published New Hope 360 - May 10 2013]

Entities: ChromaDex Corporation, nicotinamide, Dietary Supplements, Stock Option, Animal Health

First reported May 10 2013 - Updated May 10 2013 - 1 reports

ChromaDex reports 31% revenue growth in first quarter 2013

ChromaDex® Corporation (OTCQB: CDXC) ("ChromaDex" or the "Company"), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical ... [Published News-Medical.Net - May 10 2013]

Entities: ChromaDex Corporation, Revenue Growth, Dietary Supplements, Stock Option, Animal Health

First reported May 10 2013 - Updated May 10 2013 - 1 reports

CHROMADEX CORP : ChromaDex® Reports Results for the First Quarter 2013

(4-traders.com)IRVINE, Calif., May 10, 2013/PRNewswire/ -- ChromaDex® Corporation (OTCQB: CDXC) ("ChromaDex" or the "Company"), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, ... [Published 4 Traders - May 10 2013]

Entities: ChromaDex Corporation, Dietary Supplements, Animal Health

First reported May 10 2013 - Updated May 10 2013 - 5 reports

ChromaDex® Reports Results for the First Quarter 2013

--(Logo: http://photos.prnewswire.com/prnh/20110830/LA59283LOGO)For the three months ended March 30, 2013, ChromaDex reported revenue of $2,334,566, an increase of 31% as compared to $1,785,006 for the same period in 2012. The net income attributable ... [Published Sacramento Bee - May 10 2013]

Entities: ChromaDex Corporation, Common Shares Outstanding, Operating Expenses

First reported May 03 2013 - Updated May 03 2013 - 2 reports

Spherix Announces New Agreements to Develop and Market D-tagatose

D-tagatose is a natural sweetener present in only small amounts in fruits and dairy products, but it can be commercially produced through an enzymatic process beginning with other natural sugars. With the same bulk and sweetness of regular sugar (i.e., ... [Published Investors Business Daily - May 03 2013]

Entities: Spherix Incorporated, ChromaDex Corporation, Market

Quotes

...XIENCE Xpedition 48 may provide important cost savings to the system," said Peter Smits, M D , Maasstad Ziekenhuis, Rotterdam, the Netherlands. "I believe that this new treatment option, backed by the robust clinical outcomes of the XIENCE family of drug eluting stents, will help physicians in the treatment of long lesions."

CytRx Offers Initial Results from Aldoxorubicin Trial; Abbott Announces CE Mark for World's Longe ... [Published BioMedReports - May 22 2013]

Frank Jaksch, Jr., CEO and co-founder of ChromaDex, commented, "We continue to execute on our business strategy of identifying novel ingredient technologies, securing intellectual property rights, developing commercially viable production processes, validating with clinical proof and most importantly, executing on a commercialization and licensing strategy."

ChromaDex Reports Results for the First Quarter 2013 [Published Food Ingredients First - May 13 2013]

...a research professor of pharmacognosy and associate director of the National Center for Natural Products Research at the University of Mississippi. "He is a deserving recipient and I am proud to call him my friend."

Professor De-an Guo to Receive ABC's Norman R. Farnsworth Excellence in Botanical Research Award [Published AndhraNews.net - May 09 2013]

"New housing construction continued at a strong pace, and spending for home repairs and remodeling began to improve despite cooler weather in many parts of the country that held back exterior projects like windows" Chief Executive Officer Chris Klein said

MARKET PULSE-LinkedIn, Arena Pharma, Radcom, Delcath, YRC Worldwide [Published CNBC - May 03 2013]

More Content

sort by: Date \| Relevance
CytRx Offers Initial Results from Aldoxorubicin... [Published BioMedReports - May 22 2013]
Chromadex (CDXC) Insider Builds Stake As Pipeli... [Published StockHouse USA - May 21 2013]
SECFilings.com Insider Buy Breaking Alert: Chro... [Published Zecco - May 21 2013]
SECFilings.com Insider Buy Breaking Alert: Chro... [Published Marketwire - Breaking News Releases - May 21 2013]
ChromaDex, Inc. to Present at the Second Annual... [Published BioSpace - May 20 2013]
ChromaDex To Present At The Second Annual Marcu... [Published KiiiTV3.com - May 20 2013]
ChromaDex To Present At The Second Annual Marcu... [Published TickerTech.com - May 20 2013]
SupplySide MarketPlace Review: The “Next Genera... [Published Nutritional Outlook - May 16 2013]
Natural Products Ingredient Innovator Generatin... [Published Equities.com - May 15 2013]
Natural Products Ingredient Innovator Generatin... [Published Individual.com - May 15 2013]
Form 4 ChromaDex Corp. For: May 10 Filed by: Br... [Published Street Insider - May 14 2013]
Sambazon’s Dubious Success with Açaí Teaches Ch... [Published Trefis - May 13 2013]
ChromaDex Reports Results for the First Quarter... [Published Food Ingredients First - May 13 2013]
ChromaDex, Inc. Reports Results for the First Q... [Published BioSpace - May 10 2013]
ChromaDex revenue up 31% [Published New Hope 360 - May 10 2013]
ChromaDex reports 31% revenue growth in first q... [Published News-Medical.Net - May 10 2013]
CHROMADEX CORP : ChromaDex® Reports Results for... [Published 4 Traders - May 10 2013]
ChromaDex® Reports Results for the First Quarte... [Published Sacramento Bee - May 10 2013]
ChromaDex® Reports Results for the First Quarte... [Published Rock Hill Herald - May 10 2013]
ChromaDex® Reports Results for the First Quarte... [Published Reuters - May 10 2013]
ChromaDex® Reports Results for the First Quarte... [Published Zecco - May 10 2013]
ChromaDex® Reports Results for the First Quarte... [Published Yahoo! Finance - May 10 2013]
ChromaDexÂ® Reports Results for the First Quart... [Published Individual.com - May 10 2013]
ChromaDex® Reports Results for the First Quarte... [Published PR Newswire: Consumer Products & Retail - May 10 2013]
Professor De-an Guo to Receive ABC's Norman R. ... [Published AndhraNews.net - May 09 2013]
Three Top Performing Healthcare Stocks to Watch [Published Benzinga.com - May 06 2013]
New IP Company Marathon Patent Group Promises D... [Published Forbes.com - May 06 2013]
MARKET PULSE-LinkedIn, Arena Pharma, Radcom, De... [Published CNBC - May 03 2013]
Despite mixed research, antioxidants business i... [Published New Hope 360 - May 03 2013]
Spherix Announces New Agreements to Develop and... [Published Investors Business Daily - May 03 2013]